| Bioactivity | 8-Bromo-2'-deoxyguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | ||||||||||||
| Name | 8-Bromo-2'-deoxyguanosine | ||||||||||||
| CAS | 13389-03-2 | ||||||||||||
| Formula | C10H12BrN5O4 | ||||||||||||
| Molar Mass | 346.14 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
8-Bromo-2'-deoxyguanosine
CAS: 13389-03-2 F: C10H12BrN5O4 W: 346.14
8-Bromo-2'-deoxyguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeti
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.